2cureX German subsidiary receive contribution for the development of IndiTreat® tests in immuno-oncology
2cureX AB’s German subsidiary 2cureX GmbH (“2cureX”) has received funding from the German Federal Ministry of Education and Research to develop an IndiTreat® test for individualizing immuno-oncological treatment.2cureX has received a grant of 810,000 EUR from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) to adapt the IndiTreat® to individualized immuno-oncology treatment. The project is run in collaboration with the University Medical Center Hamburg-Eppendorf (Universitätsklinikum Hamburg-Eppendorf, UKE). 2cureX is co-financing the